Guidance for industry : good pharmacovigilance practices and pharmacoepidemiologic assessment.
| Corporate Authors: | Center for Drug Evaluation and Research (U.S.), Center for Biologics Evaluation and Research (U.S.) |
|---|---|
| Format: | Government Document eBook |
| Language: | English |
| Published: |
Rockville, MD :
U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,
[2005]
|
| Subjects: | |
| Online Access: | https://purl.fdlp.gov/GPO/LPS116059 |
Similar Items
Textbook of pharmacoepidemiology /
Published: (2022)
Published: (2022)
Pharmacoepidemiology /
Published: (2020)
Published: (2020)
Pharmacoepidemiology /
Published: (2012)
Published: (2012)
Guidance for industry : recommendations for assessment of donor suitability and blood and blood product safety in cases of possible exposure to anthrax.
Published: (2001)
Published: (2001)
Guidance for industry : changes to an approved application : biological products, human blood and blood components intended for transfusion or for further manufacture.
Published: (2001)
Published: (2001)
Guidance for industry : recognition and use of a standard for uniform blood and blood component container labels.
Published: (2006)
Published: (2006)
Guidance for industry : assessing donor suitability and blood and blood product safety in cases of known or suspected west Nile virus infection.
Published: (2005)
Published: (2005)
Guidance for industry : revised recommendations for the assessment of donor suitability and blood product safety in cases of suspected severe acute respiratory syndrome (SARS) or exposure to SARS.
Published: (2003)
Published: (2003)
Guidance for industry : recommendations for deferral of donors and quarantine and retrieval of blood and blood products in recent recipients of smallpox vaccine (vaccinia virus) and certain contacts of smallpox vaccine recipients.
Published: (2002)
Published: (2002)
Journal of pharmacoepidemiology.
Published: (1989)
Published: (1989)
Dictionary of pharmacoepidemiology /
by: Bégaud, Bernard
Published: (2000)
by: Bégaud, Bernard
Published: (2000)
Guidance for industry : amendment (donor deferral for transfusion in France since 1980) to "Guidance for industry, revised preventive measures to reduce the possible risk of transmission of Creutzfeldt-Jakob disease (CJD) and variant Creutzfeldt-Jakob disease (vCJD) by blood and blood products".
Published: (2006)
Published: (2006)
Guidance for industry : pre-storage leukocyte reduction of whole blood and blood compoments intended for transfusion.
Published: (2001)
Published: (2001)
Guidance for industry : revised preventive measures to reduce the possible risk of transmission of Creutzfeldt-Jakob disease (CJD) and variant Creutzfeldt-Jakob disease (vCJD) by blood and blood products.
Published: (2002)
Published: (2002)
Guidance for industry : availability of licensed donor screening tests labeled for use with cadaveric blood specimens.
Published: (2000)
Published: (2000)
Pharmacovigilance /
Published: (2007)
Published: (2007)
Guidance for industry : notifying FDA of fatalities related to blood collection or transfusion.
Published: (2003)
Published: (2003)
Guidance for industry : revised recommendations for donor and product management based on screening tests for syphilis.
Published: (2003)
Published: (2003)
Guidance for industry : year 2000 date change for computer systems and software applications used in the manufacture of blood products.
Published: (1998)
Published: (1998)
Guidance for industry : biological product deviation reporting for blood and plasma establishments.
Published: (2006)
Published: (2006)
Guidance for industry : use of sterile connecting devices in blood bank practices.
Published: (2000)
Published: (2000)
Guidance for industry : recommendations for donor questioning regarding possible exposure to malaria.
Published: (2000)
Published: (2000)
Guidance for industry : implementing a collection program for source plasma containing disease-associated and other immunoglobulin G (IgG) antibodies.
Published: (2006)
Published: (2006)
Guidance for industry : revised recommendations regarding invalidation of test results of licensed and 510(k) cleared bloodborne pathogen assays used to test donors.
Published: (2001)
Published: (2001)
Manual of drug safety and pharmacovigilance /
by: Cobert, Barton L.
Published: (2007)
by: Cobert, Barton L.
Published: (2007)
Cobert's manual of drug safety and pharmacovigilance /
by: Cobert, Barton L.
Published: (2012)
by: Cobert, Barton L.
Published: (2012)
Understanding pharmacoepidemiology /
Published: (2011)
Published: (2011)
Understanding pharmacoepidemiology /
Published: (2011)
Published: (2011)
An introduction to pharmacovigilance /
by: Waller, Patrick
Published: (2010)
by: Waller, Patrick
Published: (2010)
Guidance for industry : streamlining the donor interview process, recommendations for self-administered questionnaires.
Published: (2003)
Published: (2003)
Guidance for industry : implementation of acceptable full-length donor history questionnaire and accompanying materials for use in screening donors of blood and blood components.
Published: (2006)
Published: (2006)
Guidance for FDA reviewers : premarket notification submissions for blood and plasma warmers.
Published: (2001)
Published: (2001)
Pharmacoepidemiology and pharmacovigilance : synergistic tools to better Investigate drug safety /
by: Nour, Sabrina
Published: (2019)
by: Nour, Sabrina
Published: (2019)
Guidance for industry : class II special controls guidance document : cord blood processing system and storage container.
Published: (2007)
Published: (2007)
Pharmacoepidemiology : principles and practice /
by: Waning, Brenda
Published: (2001)
by: Waning, Brenda
Published: (2001)
Guidance for industry : supplemental testing and the notification of consignees of donor test results for antibody to hepatitis C virus (anti-HCV).
Published: (1998)
Published: (1998)
Guidance for industry : recommendations for collecting red blood cells by automated apheresis methods.
Published: (2001)
Published: (2001)
Guidance for industry for platelet testing and evaluation of platelet subsitute products.
Published: (1999)
Published: (1999)
Guidance for industries : variances for blood collection from individuals with hereditary hemochromatosis.
Published: (2001)
Published: (2001)
Guidance for FDA reviewers : premarket notification submissions for empty containers for the collection and processing of blood and blood components.
Published: (2001)
Published: (2001)